SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after delivering a strong Q4 earnings beat, achieving its first full year of GAAP profitability, and announcing a significant share buyback, prompting community discussions around a potential short squeeze and its "Agentic AI" opportunities, despite a perplexing after-hours price dip.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare is gaining significant attention as it nears Nasdaq compliance and anticipates imminent End-of-Phase 2 (EOP2) results for its fast-tracked obstructive sleep apnea drug, IHL-42X. The community is actively discussing the stock's strong momentum and potential for a short squeeze due to its reduced float, amidst varying opinions on its valuation and concerns regarding future share dilution.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow With Knife ($CAW) is trending amidst its 2nd anniversary celebration, with its community eagerly discussing ongoing developments like multichain bridging and a deflationary burn mechanism, anticipating significant future growth for the meme coin.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending after its Alpha Flight 7 successfully launched a Lockheed Martin payload, sparking renewed community optimism. Following previous delays, investors are actively discussing the implications for the company's standing within the expanding space and defense sectors.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is spiking amid escalating geopolitical tensions and attacks on oil facilities near the Strait of Hormuz, raising significant supply disruption concerns. The community is actively debating if recent strategic oil reserve releases are a sufficient buffer or merely a temporary fix against a potentially prolonged high-price environment.

Netskope, Inc. engages in the provision of cloud based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one SASE, Netskope one SSE, cloud access security broker, next generation secure web gateway, private access, cloud firewall, SD-WAN and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal, and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is trending after reporting strong revenue and ARR growth, coupled with achieving positive free cash flow for the first time, yet the stock is experiencing a sharp sell-off. The community is actively debating if the market's negative reaction is an overreaction to anticipated share dilution from an upcoming lock-up expiration or if recent guidance is truly lackluster, despite the company's strong positioning in the SASE and AI security market.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

Caesars Entertainment is trending due to exclusive buyout talks with billionaire Tilman Fertitta for around $34 per share, topping a rival bid from Carl Icahn, sparking intense community discussion among shareholders who feel the offer significantly undervalues the company.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending following a key development agreement with Tower Semiconductor to integrate its high-speed electro-optic polymer modulators, sparking significant community excitement and speculation about an indirect path to NVIDIA's AI infrastructure. This collaboration, alongside recent progress with Fortune Global 500 customers, is fueling discussions about the company's potential for hyperscaler adoption and a major re-rating in the rapidly expanding photonics market.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending on breaking news that President Trump is preparing to invoke the Defense Production Act to fast-track the restart of its California offshore oil production, overriding state regulations amid escalating global energy volatility. The community is buzzing about a potential massive short squeeze, fueled by significant short interest, and the prospect of increased domestic oil supply.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is generating significant buzz within the optical interconnect sector, vital for AI data centers, with widespread anticipation for product demonstrations at the OFC Conference. Community discussion centers on potential major partnership announcements, fueled by Marvell Technology's strategic involvement with a company already utilizing POET's technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years

Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.0% during the third quarter, according to the company in its most recent Form 13F filing...

Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD

Magnetar Financial LLC boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 201.0% in the third quarter, according to the company in its most recent 13F filing with...

What 16 Analyst Ratings Have To Say About Gilead Sciences

Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group

Jefferies Financial Group started coverage on Gilead Sciences in a research note on Tuesday. They issued a "buy" rating and a $180.00 target price for the company...

Gilead Sciences, Inc. $GILD Shares Sold by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 53.5% in the third quarter, according to the company in its most recent disclosure with the...

Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors

Capital Research Global Investors decreased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.5% during the 3rd quarter, according to the company in its most recent 13F filing with...

Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD

Legal & General Group Plc lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and...

Grantham Mayo Van Otterloo & Co. LLC Acquires 68,006 Shares of Gilead Sciences, Inc. $GILD

Grantham Mayo Van Otterloo & Co. LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 283.7% in the 3rd quarter, according to the company in its most recent 13F filing with...

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twenty-seven analysts that are presently covering the firm, Marketbeat...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

GILD
Gilead Sciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GILD News

GILDGilead Sciences, Inc.